Legal & General Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.33M Buy
52,681
+1,523
+3% +$96.2K ﹤0.01% 1743
2025
Q1
$2.71M Sell
51,158
-645
-1% -$34.2K ﹤0.01% 1814
2024
Q4
$2.9M Buy
51,803
+951
+2% +$53.2K ﹤0.01% 1829
2024
Q3
$2.66M Buy
50,852
+1,081
+2% +$56.6K ﹤0.01% 1855
2024
Q2
$2.04M Buy
49,771
+2,355
+5% +$96.7K ﹤0.01% 1942
2024
Q1
$2.05M Buy
47,416
+588
+1% +$25.5K ﹤0.01% 1932
2023
Q4
$2.15M Buy
46,828
+3,674
+9% +$169K ﹤0.01% 1913
2023
Q3
$989K Buy
43,154
+501
+1% +$11.5K ﹤0.01% 2195
2023
Q2
$703K Buy
42,653
+25,534
+149% +$421K ﹤0.01% 2344
2023
Q1
$305K Buy
17,119
+2,323
+16% +$41.4K ﹤0.01% 2447
2022
Q4
$431K Buy
14,796
+5,028
+51% +$146K ﹤0.01% 2373
2022
Q3
$239K Sell
9,768
-2,479
-20% -$60.7K ﹤0.01% 2560
2022
Q2
$51K Sell
12,247
-1,016
-8% -$4.23K ﹤0.01% 2998
2022
Q1
$153K Hold
13,263
﹤0.01% 2759
2021
Q4
$132K Hold
13,263
﹤0.01% 2850
2021
Q3
$173K Buy
13,263
+6,811
+106% +$88.8K ﹤0.01% 2731
2021
Q2
$127K Sell
6,452
-4
-0.1% -$79 ﹤0.01% 2665
2021
Q1
$137K Buy
6,456
+1,335
+26% +$28.3K ﹤0.01% 2529
2020
Q4
$152K Sell
5,121
-56
-1% -$1.66K ﹤0.01% 2481
2020
Q3
$112K Sell
5,177
-1,463
-22% -$31.7K ﹤0.01% 2455
2020
Q2
$148K Buy
6,640
+799
+14% +$17.8K ﹤0.01% 2429
2020
Q1
$85K Sell
5,841
-1,303
-18% -$19K ﹤0.01% 2457
2019
Q4
$164K Buy
7,144
+2,927
+69% +$67.2K ﹤0.01% 2445
2019
Q3
$91K Hold
4,217
﹤0.01% 2554
2019
Q2
$93K Buy
4,217
+1,362
+48% +$30K ﹤0.01% 2557
2019
Q1
$79K Buy
2,855
+180
+7% +$4.98K ﹤0.01% 2564
2018
Q4
$71K Hold
2,675
﹤0.01% 2567
2018
Q3
$78K Buy
2,675
+850
+47% +$24.8K ﹤0.01% 2580
2018
Q2
$57K Buy
1,825
+383
+27% +$12K ﹤0.01% 2693
2018
Q1
$29K Hold
1,442
﹤0.01% 2991
2017
Q4
$42K Buy
+1,442
New +$42K ﹤0.01% 2930